Gerald stated that lympro would generate revenue in 2015 in his call today. He also stated in previous press releases that revenue would come in late 2014. Looks like then delay in data gathering has pushed everything back a quarter or so. Gerald also finally explained why the full data set was not available by the end of July 31st. Their vendor to fill the trial quit on them. This is the first I have heard of this.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links
My Agenda: To see Amarantus prosper so I can make a nice return on my investment.